Browse > Article
http://dx.doi.org/10.5487/TR.2009.25.4.189

Establishment of a Stable Cell Line Expressing Green Fluorescence Protein-fused Hypoxia Inducible Factor-1α for Assessment of Carcinogenicity of Chemical Toxicants  

Kim, Sung-Hye (College of Pharmacy, Seoul National University)
Seo, Hee-Won (College of Pharmacy, Seoul National University)
Lee, Min-Ho (College of Pharmacy, Seoul National University)
Chung, Jin-Ho (College of Pharmacy, Seoul National University)
Lee, Byung-Hoon (College of Pharmacy, Seoul National University)
Lee, Mi-Ock (College of Pharmacy, Seoul National University)
Publication Information
Toxicological Research / v.25, no.4, 2009 , pp. 189-193 More about this Journal
Abstract
Hypoxia inducible factor $1\alpha$ (HIF-$1\alpha$) is a potential marker of carcicnogenesis since it is overexpresssed in many human cancers such as brain, breast, and uterus, and its role has implicated in tumor cell growth and metastasis. In this study, we established a stable cell line that express green fluorescence protein (GFP)-fused hypoxia inducible factor $1\alpha$ (HIF-$1\alpha$) and evaluated the potential use of this cell line for assessment of carcinogenicity of chemical toxicants. Western blot analysis as well as fluorescence measurements showed that protein-level of GFP-HIF-$1\alpha$ was significantly enhanced in a dose-dependent manner upon treatment of hypoxia mimicking agents such as dexferrioxamine and $CoCl_2$. Well-Known tumor promoters such as mitomycin and methyl methanesulfonate. significantly induced the fluorescence intensity of GFP-HIF-$1\alpha$, whereas the known negative controls such as o-anthranilic acid and benzethonium chloride, did not. These results indicate that HIF-$1\alpha$ could be a biological parameter for detection of tumor initiators/promoters and suggest that the GFP-HIF-$1\alpha$ cell line is a useful system for screening of carcinogenic toxicants.
Keywords
GFP-HIF-$1\alpha$ stable cell line; Chemical toxicants; Carcinogenicity;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Biner, P., Schindl, M., Obermair, A., Breitenecker, G and Oberhuber, G (2001). Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res., 7, 1661-1668   PUBMED
2 Breheny, D., Zhang, J. and Massey, ED. (2005). Application of a two-stage Syrian hamster embryo celi transformation assay to cigarette smoke particulate matter. Mutat. Res., 572, 45-57   DOI   PUBMED   ScienceOn
3 Burri, P, Djonov, V, Aebersold, D.M., Lindel, K., Studer, U., Altermatt, H.J., Mazzucchelli, L., Greiner, RH. and Gruber, G (2003). Significant correlation of hypoxia-inducible factor-1 alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int. J. Radiat. Oncol.Biol. Phys., 56, 494-501   DOI   ScienceOn
4 Chilakapati, J., Shankar, K., Korrapati, M.C., Hill, R.A. and Mehendale, H.M. (2005). Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metabo. Dispos., 33, 1877-1885
5 Grover, PL., Sins, P, Huberman, E., Marquardt, H., Kuroki, T. and Heidelberger, C. (1971). In vitro transformation of rodent cells by k-region derivatives of polycyclic hydrocarbons. Proc. Nat. Acad. Sci. USA, 68, 1098-1101   DOI   ScienceOn
6 Lee, J.W, Bas, S.H., Jeong, J.W, Kim, S.H. and Kim, K.W. (2004). Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp. Mol. Med., 36, 1-12   DOI   PUBMED   ScienceOn
7 Machon, PC., Hirota, K. and Semenza, GL. (2001). FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev., 15, 2675-2686   DOI   ScienceOn
8 Mangipudy, R.S., Rao, P.S. And Mehendale, H.M. (1996). Effect of an antimitotic agent colchicines on thioacetamide hepatotoxicity. Environ. Health Perspect., 104, 744-749   DOI   ScienceOn
9 Semenza, GL. (2003). Targeting HIF-1 for cancer therapy. Cancer, 3, 721-732
10 Swinson, D.E., Jones, J.L., Cox, G, Richardson, D., Harris, A.L. and O'Byrne, K.J. (2004). Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int. J. Cancer., 111, 43-50   DOI   ScienceOn
11 Tsuchiya, T. and Umeda, M. (1997). Relationship between exposure to TPA and appearance of transformed cells in MNNG-initiated transformation of BALB/c3T3 cells. Int. J. Cancer, 73, 271-276   DOI   ScienceOn
12 Vesselinovitch, S.D. and Mihailovich, N.T. (1968). The inhibitory effect of greseofulvin on the 'promotion' of skin carcinogenesis. Cancer Res., 28, 2463-2465   PUBMED
13 Wyatt, M.D. and Pittman, D.L. (2006). Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. Chem. Res. Toxicol., 19, 1580-1594   DOI   ScienceOn
14 Yoo, YG, Yeo, M.G, Kim, DK, Park, H. and Lee, M.O. (2004). Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1 alpha. J. BioI. Chem., 279, 53365-53373   DOI   ScienceOn
15 Zhong., H., De Marzo, AM., Laughner, E., Lim, M., Hilton, D.A., Zag zag D., Buechler, P, Isaacs, WB., Semenza, GL. and Simons, J.W (1999). Overexpression of hypoxiainducible factor 1 a in commom human cancers and their metastases. Cancer Res., 835, 5830-5835
16 Trosko, J.E. (2001). Commentary: Is the concept of 'tumor promotion' a useful paradigm? Mol. Carcinog., 3, 131-137
17 Tennant, RW, Margolin, B.H., Shelby, M.D., Zeiger E., Haseman, J.K. Spalding, J., Caspary, W, Resnck, M., Stasiewicz, S., Anderson, E. and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941   DOI   PUBMED
18 Haseman, J.K., Huff, J.E., Zeiger, E. and McConnell, E.E. (1987). Comparative results of 327 chemical carcinogenicity studies. Environ. Health Perspect., 74, 229-235   DOI   ScienceOn
19 Fang, M.l., Kim, DY, Lee, HW and Cho, M.H. (2001). Improvement of in vitro two-stage transformation assay and determination of the promotional effect of cadmium. Toxicol. In Vitro, 15, 225-231   DOI   ScienceOn
20 Tomasz, M., Mercado, C.M., Olson, J. and Chatterjie, N. (1974). Mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. Biochemistry, 13,4878-4887   DOI   ScienceOn
21 Huang, L.E., Gu, J., Sxhau, M. amd Bunn, H.F. (1998). Regulation of hypoxia-inducible factor 1 alpha is mediated by an 02-dependent degradation domain via the ubiquitinproteasome pathway. Proc. Natl. Acad. Sci. U.S.A., 95, 7987-7992   DOI   ScienceOn
22 Spalding, J.W, French, J.E., Tice, R.R Furedi-Machacek, M., Haseman, JK and Tennant, R.W (1999). Development of a transfenic mouse model for carcinogenesis bioassays: Evaluation of chemically induced skin tumors in Tg.AC mice. Toxicol. Sci., 49, 241-254   DOI   ScienceOn
23 Lee, MY, Kim, M.A., Kim, H.J., Bae, YS., Park, J.I., Kwak, JY, Chung, J.H. and Yun, J. (2007). Alkylating agent methyl methanesulfonate (MMS) induces a wave of global protein hyperacetylation: Implications in cancer cell death. Biochem. Biophys. Res. Commum., 360, 483-489   DOI   ScienceOn
24 Berwald, Y. and Sachs, L. (1963). In vitro celi transformation with chemical carcinogens. Nature, 200, 1182-1184   DOI   PUBMED   ScienceOn
25 Hong, I., Seo, HW, Lee, M.H., Kim, JW, Chung, J.H., Lee, B.H. and Lee, M.O. (2007). Establishment of reporter cell lines that monitor activities of hypoxia inducible factor1, P53 and Nur77 for assessment of carcinogenicity. J. Toxicol. PUb. Health, 23, 231-238
26 Labay, K., Ould-Elhkim, M., Kles, V, Guffroy, M., Poul, J.M. and Sanders, P (2001). Effects of griseofulvin in mediumterm liver carcinogenesis assay and peripheral blood micronucleus test in rat. Teratog. Carcinog. Mutagen., 21, 441-451   DOI   ScienceOn
27 Custer, L., Gibson, D.P., Aardema, M.J. and LeBoeuf, R.A. (2000). A refined protocol for conducting the low pH 6.7 Syrian hamster embryo (SHE) cell transformation assay. Mutat. Res., 455, 129-139   DOI   PUBMED   ScienceOn
28 Schindl, M., Schoppmann, S.F., Samonigg, H., Hausmananinger, H., Kwasny, W, Gnant, M., Jakesz, R., Kubista, E., Birner, P., Pberhuber, G, Austrian Breast and Colorectal Cancer Study Group. (2002). Overexpression of hypoxia-inducible factor 1 alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin. Cancer Res., 8, 1831-1837   PUBMED
29 Tennant, R.W (1988). Relationships between in vitro genetic toxicity and carcinogenisity studies in animals. Ann. N. Y. Acad. Sci., 534, 127-132   DOI   PUBMED   ScienceOn
30 Humble, N.M., Trempus, C.S., Spalding, J.W, Cannon, R.E. and Tennant, RW (2005). Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review. Oncogene, 24, 8217-8228   DOI   ScienceOn
31 Zagzag. D., Zhong, H., Scalzitti, J.M., Laughner, E., Simons, J.W and Semenza, G L. (2000). Expression of hypoxiainducible factor 1a in brain tumors. Cancer, 88, 2606-2618   DOI   ScienceOn
32 Becerril, C., Ferrero, M., Sanz, F. and Castano, A. (1999). Detection of mitomycin C-induced genetic damage in fish celis by use of RAPD. Mutagenesis, 14, 449-456   DOI   ScienceOn